| Directorate Changes | 29-Sep-2025 | 07:00 | RNS |
| Interim results for the six months to 30 June 2025 | 25-Sep-2025 | 07:00 | RNS |
| Co-Development Agreement & Monetisation Deal | 25-Sep-2025 | 07:00 | RNS |
| Notice of Interim Results | 24-Sep-2025 | 09:30 | RNS |
| Positive FDA Feedback on Phase 2 Study Design | 04-Sep-2025 | 07:00 | RNS |
| Holding(s) in Company | 28-Aug-2025 | 12:00 | RNS |
| Change of Auditor | 08-Aug-2025 | 07:00 | RNS |
| Grant of Options and PDMR Dealing | 04-Jun-2025 | 07:00 | RNS |
| Result of AGM | 02-Jun-2025 | 13:32 | RNS |
| Non-Executive Director Board Change | 02-Jun-2025 | 07:00 | RNS |
| Director/PDMR Dealing | 21-May-2025 | 07:00 | RNS |
| Arecor Partnership with Skye Bioscience | 19-May-2025 | 07:00 | RNS |
| Director Dealing | 14-May-2025 | 14:37 | RNS |
| Arecor sells rights to non-Ogluo® products | 08-May-2025 | 07:00 | RNS |
| Posting of 2024 Annual Report and Notice of AGM | 06-May-2025 | 16:42 | RNS |
| Currency | UK Pounds |
| Share Price | 71.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 86.50p |
| 52 Week Low | 38.00p |
| Volume | 35,393 |
| Shares Issued | 37.76m |
| Market Cap | £27.00m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 13:13 | 27,300 @ 70.10p |
| 11:01 | 62 @ 70.10p |
| 11:00 | 848 @ 70.10p |
| 09:00 | 4,349 @ 72.00p |
| 09:00 | 99 @ 72.00p |
You are here: research